Explore how CAR-T cell therapy is transforming hematological malignancy treatment through engineered immune cells, current FDA-approved therapies, and future innovations.
Explore how CAR-T therapy is revolutionizing HIV treatment by engineering immune cells to target and eliminate HIV-infected cells, potentially leading to functional cures.
Explore how modified antagonistic antibodies are revolutionizing medicine by blocking harmful cellular processes in cancer, autoimmune diseases, and inflammatory disorders.
Explore how engineered peptides and mutant polypeptides are transforming immunotherapy through advanced delivery systems and groundbreaking cancer research.
Explore how IL-13Rα2-targeted therapy is revolutionizing glioblastoma treatment and understanding cancer therapy escape mechanisms.
Exploring combined CTLA-4 and PD-1/PD-L1 blockade therapy for bovine leukemia virus-infected cattle and its potential impact on veterinary medicine.
Explore the evolution of anticancer drug development from chemotherapy to precision therapies, computational methods, and future innovations in cancer treatment.
Discover how peripheral blood T-cell receptor repertoire profiling can predict immunotherapy success in advanced non-small cell lung cancer patients.
Explore how T-cell receptor sequencing is transforming bladder cancer treatment by decoding the immune system's response to tumors and predicting immunotherapy outcomes.
Learn how axalimogene filolisbac, a modified foodborne bacterium, is transforming cervical cancer treatment through innovative immunotherapy approaches.